Company: STAA
Filing Date: 2025-09-16
Form Type: DEFM14A
Source: 0001193125-25-204396
Chunk: 98

Company: STAAR SURGICAL CO
Filing Date: 2025-09-16
Form: DEFM14A
Chunk 98
---
 expectations for net sales of ICLs and new product introductions. Management considered multiple factors, including emerging competition in China, that could impact growth rates
and overall future financial results to arrive at the expectations reflected in the Projections. Relative to the Projections, the July Diligence Projections assumed incremental ICL net sales in 2026 and 2027 and incremental net sales attributable to
ongoing and accelerated new product introductions in 2027. In early August 2025, the Projections were provided to the Board in connection with its evaluation of the Merger, and were provided to Citi and approved by STAAR for Citi’s use and
reliance in connection with Citi’s financial analysis and opinion as summarized in “Proposal 1: Adoption of the Merger Agreement—Opinion of STAAR’s Financial Advisor.”

Both of the Projections and the July Diligence Projections reflect STAAR on a standalone basis without giving effect to the Merger, including
any impact of the negotiation or execution of the Merger Agreement, the expenses that may be incurred in connection with the Merger, the effect of any business or strategic decision or action that has been or will be taken as a result of the Merger
Agreement having been executed or in anticipation of the Merger, or the effect of any alteration, acceleration, postponement or decision not to take any business or strategic decisions or actions which would likely have been taken if the Merger
Agreement had not been executed but which were instead altered, accelerated, postponed or not taken in anticipation of Merger. Further, the financial projections do not take into account the effect of any failure of the Merger to be consummated and
should not be viewed as accurate or continuing in that context. Although the July Diligence Projections were presented to the Board in connection with its review of the Projections, only the Projections were approved by STAAR for Citi’s use
and reliance, and were used and relied upon by Citi, in connection with its financial analysis and fairness opinion.

The financial
projections were not intended for public disclosure, and, accordingly, do not necessarily comply with, nor were they prepared with a view toward compliance with, the published guidelines of the SEC, the guidelines established by the American
Institute of Certified Public Accountants for preparation and presentation of financial forecasts or generally accepted accounting principles, or GAAP (and do not include footnote disclosures as may be required by GAAP). Neither STA